Frazier Life Sciences Public Fund, L.P. 13D/13G Filings for Autolus Therapeutics plc (AUTL)

Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Autolus Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-14
12:09 pm
Purchase
2022-12-31 13G Autolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund, L.P. 3,746,857
2.200%
16,200increase
(+0.43%)
Filing
2021-12-17
2:37 pm
Purchase
2021-12-13 13G Autolus Therapeutics plc
AUTL
Frazier Life Sciences Public Fund, L.P. 3,730,657
5.100%
3,730,657increase
(New Position)
Filing